Breakdown | ||||
Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
3.17B | 2.83B | 2.75B | 2.18B | 1.68B | Gross Profit |
2.21B | 2.02B | 1.90B | 1.47B | 1.15B | EBIT |
85.26M | 53.55M | 83.51M | -98.40M | -230.03M | EBITDA |
285.85M | 222.49M | 183.94M | -8.67M | -168.72M | Net Income Common Stockholders |
106.74M | 61.31M | 73.07M | -143.26M | -282.08M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
1.52B | 1.53B | 1.58B | 1.41B | 1.25B | Total Assets |
3.96B | 3.66B | 3.55B | 3.14B | 2.82B | Total Debt |
281.15M | 272.25M | 750.69M | 915.36M | 908.41M | Net Debt |
-442.43M | -430.28M | 169.83M | 449.16M | 571.26M | Total Liabilities |
2.66B | 2.39B | 2.60B | 2.38B | 2.07B | Stockholders Equity |
1.31B | 1.27B | 941.23M | 754.34M | 750.01M |
Cash Flow | Free Cash Flow | |||
526.87M | 482.56M | 609.10M | 307.84M | 92.67M | Operating Cash Flow |
753.60M | 677.72M | 767.23M | 410.13M | 187.64M | Investing Cash Flow |
-218.20M | 3.25M | -221.41M | -153.28M | -418.11M | Financing Cash Flow |
-509.78M | -560.24M | -431.17M | -127.79M | 200.24M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
72 Outperform | $15.60B | 156.39 | 8.29% | ― | 11.92% | 74.08% | |
70 Outperform | $19.05B | 17.09 | 114.33% | 2.25% | 5.46% | 23.49% | |
70 Outperform | $66.01B | 14.83 | -179.12% | 1.97% | 7.84% | 42.63% | |
69 Neutral | $15.54B | 8.47 | 28.62% | ― | 21.22% | ― | |
66 Neutral | $19.70B | 13.46 | -109.27% | 3.05% | 36.29% | ― | |
63 Neutral | $24.46B | 9.32 | 84.33% | 4.35% | 1.03% | -18.56% | |
60 Neutral | $10.94B | 10.48 | -7.04% | 2.99% | 7.55% | -12.20% |